NCT01066234View on ClinicalTrials.gov

Adjuvant CCRT vs CT in Minimal N2 NSCLC

PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

October 23, 2017

Primary Completion Date

January 18, 2021

Study Completion Date

January 18, 2021

Conditions
Non-small Cell Lung Cancer
Interventions
RADIATION

concurrent chemoradiotherapy

weekly paclitaxel 50mg/m2 plus weekly cisplatin 25mg/m2 5times with concurrent radiotherapy (5000rad/25fx) for 5 weeks followed by 2 cycles of 3-weekly paclitaxel (175mg/m2) plus cisplatin 80mg/m2.

DRUG

chemotherapy only

four cycles of 3-weekly paclitaxel (175mg/m2) and carboplatin (AUC5.5).

Trial Locations (1)

Unknown

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT01066234 - Adjuvant CCRT vs CT in Minimal N2 NSCLC | Biotech Hunter | Biotech Hunter